Metastatic Kidney Cancer: Difference between revisions
Urology4all (talk | contribs) |
Urology4all (talk | contribs) |
||
| Line 38: | Line 38: | ||
==== Cytokine Therapy (IFN-'''α)''' ==== | ==== Cytokine Therapy (IFN-'''α)''' ==== | ||
* | *Meta-analysis of 2 trials (SWOG 8949 and EORTC 30947) found significantly improved OS by 5.8 months in CN followed by IFN- α group (13.6 months CN IFN α2b vs. 7.8 months IFN α2b, p=0.02) vs. IFN- α alone | ||
===== <span style="color:#ff00ff">SWOG 8949 ===== | ===== <span style="color:#ff00ff">SWOG 8949 ===== | ||